Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Functional proteogenomics reveals biomarkers and therapeutic targets in lymphomas

12 Jun 2017

Abstract excerpt

Significance An important goal in precision oncology is the identification of biomarkers and therapeutic targets. We identified and annotated a compendium of N-glycoproteins from diverse human lymphoid neoplasia, an attractive class of proteins with potential to serve as cancer biomarkers and therapeutic targets. In anaplastic lymphoma kinase-positive (ALK + ) anaplastic large cell lymphoma (ALCL), integration of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glycosylation and Glycoproteins Research
Share to Lymphoma Diagnosis and Treatment
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28607076
DOI: 10.1073/pnas.1701263114

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Functional proteogenomics reveals biomarkers and therapeutic targets in lymphomasPMID 28607076Read ↗

Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemiaSemantic proximity Read ↗

The Origin, Diagnosis, and Prognosis of Oligomannose-Type Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

Pan-cancer proteogenomics expands the landscape of therapeutic targetsSemantic proximity Read ↗

Proteomic profiling based classification of CLL provides prognostication for modern therapy and identifies novel therapeutic targets.Semantic proximity Read ↗

The origin, diagnosis, and prognosis of oligomannose-type diffuse large B-cell lymphomaSemantic proximity Read ↗

Proteogenomics refines the molecular classification of chronic lymphocytic leukemiaSemantic proximity Read ↗

Proteogenomics refines the molecular classification of chronic lymphocytic leukemia.Semantic proximity Read ↗

Joint Secondary Transcriptomic Analysis of Non-Hodgkin’s B-Cell Lymphomas Predicts Reliance on Pathways Associated with the Extracellular Matrix and Robust Diagnostic BiomarkersSemantic proximity Read ↗

Transcriptomic meta-analysis of non-Hodgkin’s B-cell lymphomas reveals reliance on pathways associated with the extracellular matrixSemantic proximity Read ↗

The transcriptional landscape of glycosylation-related genes in cancerSemantic proximity Read ↗

Gene Expression Signature Associated with Clinical Outcome in ALK-Positive Anaplastic Large Cell LymphomaSemantic proximity Read ↗

The proteomic signature of NPM/ALK reveals deregulation of multiple cellular pathwaysSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.